Exelixis In-Licenses Second Anti-Cancer Compound from Aurigene Following the US FDA's Acceptance of IND for P-I Study of XL114 in...
October 15, 2021
Denovo In-Licenses Lundbeck's Idalopirdine for Alzheimer's Disease and Other Indications
July 2, 2021
Novartis In-Licenses Fibroblast Activation Protein (FAP) to Expand its Oncology Radioligand Pipeline
March 31, 2021
Novartis In-Licenses BieGene's Tislelizumab to Expand its Oncology Portfolio
January 12, 2021
Axsome In-Licenses Pfizer's Reboxetine and Esreboxetine in the US
January 14, 2020
Bausch Health In-Licenses Clearside's Xipere (triamcinolone acetonide suprachoroidal injectable suspension) For Macular Edema Asso...
October 24, 2019
Back to Home
Incisive News in 3 Shots.
First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
Terms of Service
Copyright © 2023 PharmaShots - All Rights Reserved.